TORAYMYXIN | 合法醫療器材資訊網

Toraymyxin®isthereferenceforthetreatmentofpatientswithendotoxicsepticshockwhoareunresponsivetoconventionaltherapies.Withitsoutstanding ...

Toraymyxin® – Polymyxin B hemoperfusion therapy – (Toray Industries Ltd., Japan) is the state-of-the-art therapy for the treatment of patients with endotoxic septic shock who are unresponsive to conventional treatment. More than 200,000 patients have been treated with this innovative therapy and more than 400 peer-reviewed articles have been published demonstrating the safety and effectiveness of Polymyxin B hemoperfusion therapy.

Polymyxin B hemoperfusion therapy takes advantage of the strong endotoxin neutralizing capability of Polymyxin B intelligently immobilized to polystyrene fibers. The innovation by TORAY enabling Polymyxin B (polycationic antibiotic) therapy by means of extracorporeal hemoperfusion has provided the most effective therapy for the neutralization of endotoxin, a pathogenic substance, and potent killer, when present in the bloodstream.

 Tor...